Search

Your search keyword '"immune therapy"' showing total 48 results

Search Constraints

Start Over You searched for: Descriptor "immune therapy" Remove constraint Descriptor: "immune therapy" Journal frontiers in oncology Remove constraint Journal: frontiers in oncology
48 results on '"immune therapy"'

Search Results

1. A retrospective comparison of induction chemoimmunotherapy versus chemotherapy followed by concurrent chemoradiotherapy and consolidation immunotherapy in stage III non-small cell lung cancer.

2. Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma.

3. Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma

6. A retrospective comparison of induction chemoimmunotherapy versus chemotherapy followed by concurrent chemoradiotherapy and consolidation immunotherapy in stage III non-small cell lung cancer.

7. Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment.

8. Emerging Therapies in Penile Cancer.

9. Emerging Therapies in Penile Cancer

10. Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study.

12. Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study

13. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis

14. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis.

15. Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent

16. Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent.

17. Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma

18. Targeted Therapies and Biomarkers in Small Cell Lung Cancer

20. CAR T Cell Therapy for Pediatric Brain Tumors.

21. Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma.

22. Targeted Therapies and Biomarkers in Small Cell Lung Cancer.

23. Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma

24. Turning the Tide Against Regulatory T Cells

25. Turning 'Cold' Into 'Hot' Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers

26. Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma.

27. Turning the Tide Against Regulatory T Cells.

28. Turning "Cold" Into "Hot" Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers.

29. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer

30. Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection

31. Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy

32. immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases--implications for intraoperative Radiotherapy after Resection.

33. Current immunotherapeutic Strategies to enhance Oncolytic virotherapy.

34. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis

35. Recent technological advances in using mouse models to study ovarian cancer

38. Recent technological advances in using mouse models to study ovarian cancer.

39. Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent

40. CAR T Cell Therapy for Pediatric Brain Tumors

41. Targeted Therapies and Biomarkers in Small Cell Lung Cancer

42. Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

43. How does ionizing irradiation contribute to the induction of anti-tumor immunity?

44. Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment.

45. How does ionizing irradiation contribute to the induction of anti-tumor immunity?

46. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer

47. Down Regulation of c-FLIP L Enhance PD-1 Blockade Efficacy in B16 Melanoma.

48. The confluence of radiotherapy and immunotherapy

Catalog

Books, media, physical & digital resources